Exogenous IFNλ1 further improved antifungal killing capacity of CF-neutrophils presenting a plausible future therapeutic strategy.<h4>Funding</h4>This study was funded by the Cystic Fibrosis Trust (SRC015). Here, IFNL1 is linked to cystic fibrosis.